• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/155 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Patent holdings for IPC class C07D 295/155

Total number of patents in this class: 383

10-year publication summary

43
24
27
29
19
15
28
15
18
12
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Bristol-myers Squibb Company
4848
10
The Regents of the University of California
20230
10
Duke University
3103
7
Boehringer Ingelheim International GmbH
4648
6
Amyris, Inc.
381
6
The Cooper Health System
40
6
Nerviano Medical Sciences S.r.l.
251
6
Janssen Pharmaceutica N.V.
3349
5
Abbott Laboratories
2365
5
Aurimmed Pharma, Inc.
7
5
CHDI Foundation, Inc.
106
5
SRI International
997
5
Tetraphase Pharmaceuticals, Inc.
51
5
VALO Health, Inc.
176
5
Centre National de La Recherche Scientifique
10635
4
President and Fellows of Harvard College
6024
4
Abbvie Inc.
1812
4
Arena Pharmaceuticals, Inc.
362
4
Genfit
281
4
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
75
4
Other owners 273